In addition, copy number gains or amplifications target the genes encoding for the canonical NF-κB subunit c-REL and the non-canonical NF-κB pathway kinase NIK in 50% and 25% of cHL cases, respectively [121,122,123,124]. The gene discussed is NFKB1; the disease is classic Hodgkin lymphoma.